Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-17

Clinical Trial Update: MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)

View source ↗

Summary

A ClinicalTrials.gov entry describing SURVEILLANCE-II, a study using MRD-guided surveillance for patients with resectable stage IV metastatic colorectal cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer (CRC), Colorectal Cancer Liver Metastases (CRLM) | Status: NOT_YET_RECRUITING